Science

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

Nicholas van As/royalmarsden.nhs.uk

Dec 30, 2024, 12:25

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

A recent paper by Nicholas van As, Medical Director of The Royal Marsden NHS Foundation Trust, was mentioned by Ioannis Goumas, Chief of Urology, Blessed Matteo Clinical Institute, San Donato Group, on X:

“I’m reading ‘At 2 years, 16/32 (50%) prostatectomy and three of 46 (6.5%) SBRT participants used one or more urinary pads daily (p < 0.001)’

And what about all the fancy outcomes of robotic Px?”

“Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial”

Authors: Nicholas van As, Binnaz Yasar, Clare Griffin, Stephanie Burnett, Emma Hall et al.

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

Binnaz Yasar cancer Clare Griffin Emma Hall Ioannis Goumas Nicholas van As OncoDaily Oncology prostate cancer Radical Prostatectomy radiotherapy Stephanie Burnett

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer